The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Jenoptik Down for Year’s First Half, Reports $389.9M in Revenue

    Article obtained from Photonics RSS Feed.

    Jenoptik concluded the first half of its year with a reported revenue of €329 million ($389.9 million), a year-over-year decrease of 14.1%. For the quarter, the company’s revenue dropped 17.4% to €164.6 million ($194.3 million).

    Compared to 2019, earnings per share fell 56.6% for the six-month period ending in June 2020, and 22.8% for the quarter. Quarterly earnings per share reached €0.19 ($0.23).

    “After a solid start to the year, the second quarter has seen a weaker order situation, as we expected,” said Stefan Traeger, Jenoptik president and CEO. “However, we are confident of achieving improved business performance in the second half-year. Key to this has been our comprehensive and…

    Aug, 06 2020 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.